Literature DB >> 3390052

The configuration of peripapillary tissue in unilateral glaucoma.

J Nevarez1, E J Rockwood, D R Anderson.   

Abstract

We compared the peripapillary scleral and choroidal halos and crescents in the two eyes of 42 patients with unilateral glaucoma. In most cases, the edge of the three tissue layers (the retinal pigment epithelium [RPE], the choroid, and the sclera) that encircle the optic nerve head of the glaucomatous eye superimposed exactly on the mirror images of the edges in the fellow nonglaucomatous eye. Although the size of the peripapillary crescent or halo was the same in both eyes, it and the scleral rim were often more conspicuous in the eye with glaucomatous damage because the tissue edges were seen more easily through the reduced thickness of nerve fiber layer tissue. There were nine exceptions. In five cases, the peripapillary choroidal crescent (the area of choroid not covered by RPE) was larger in the glaucomatous eye. In four eyes, however, the crescent was larger in the nonglaucomatous eye, although the magnitude of the asymmetry was less in these four cases. Thus, in late stages of optic nerve damage, there was some RPE atrophy, but in most cases of glaucoma, the area of bared choroid was the inherent anatomic configuration of the optic nerve exit canal.

Entities:  

Mesh:

Year:  1988        PMID: 3390052     DOI: 10.1001/archopht.1988.01060140047021

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

1.  Optical coherence tomography disc assessment in optic nerves with peripapillary atrophy.

Authors:  Edward Lai; Gadi Wollstein; Lori Lyn Price; Lelia A Paunescu; Paul C Stark; James G Fujimoto; Joel S Schuman
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 Nov-Dec

2.  Comparison of clinical and three-dimensional histomorphometric optic disc margin anatomy.

Authors:  Nicholas G Strouthidis; Hongli Yang; J Crawford Downs; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

3.  Optic disc histomorphometry in normal eyes and eyes with secondary angle-closure glaucoma. II. Parapapillary region.

Authors:  J B Jonas; K A Königsreuther; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

4.  Peripapillary atrophy in unilateral capsular glaucoma.

Authors:  P Puska; C Raitta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

5.  Effect of myopia and age on optic disc margin anatomy within the parapapillary atrophy area.

Authors:  Young Hoon Hwang; Jong Jin Jung; Young Min Park; Yong Yeon Kim; Sungwook Woo; Joo Hwa Lee
Journal:  Jpn J Ophthalmol       Date:  2013-07-13       Impact factor: 2.447

6.  Optic disc morphology in juvenile primary open-angle glaucoma.

Authors:  J B Jonas; A Gründler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

7.  Comparison of clinical and spectral domain optical coherence tomography optic disc margin anatomy.

Authors:  Nicholas G Strouthidis; Hongli Yang; Juan F Reynaud; Jonathan L Grimm; Stuart K Gardiner; Brad Fortune; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

8.  Direct clinico-histological correlation of parapapillary chorioretinal atrophy.

Authors:  T Kubota; J B Jonas; G O Naumann
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

9.  Three-dimensional histomorphometry of the normal and early glaucomatous monkey optic nerve head: neural canal and subarachnoid space architecture.

Authors:  J Crawford Downs; Hongli Yang; Christopher Girkin; Lisandro Sakata; Anthony Bellezza; Hilary Thompson; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

10.  Peripapillary atrophy in the unilateral exfoliation syndrome.

Authors:  Päivi Puska; Mika Harju; Ron Liebkind
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.